Johnson & Johnson (JNJ) Net Cash Flow (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Net Cash Flow came in at -$1.3 billion in Q2 2026, up 93.66% year-over-year from -$656.3 million in Q2 2025, and down 163.42% quarter-over-quarter from $2.0 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Net Cash Flow (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Net Cash Flow across 18 years of filings, most recently posting -$1.3 billion for Q2 2026.
- In Q2 2026, Net Cash Flow rose 93.66% year-over-year to -$1.3 billion; the TTM figure through Jun 2026 stood at $1.9 billion (up 129.29% YoY), while the FY2025 annual figure was -$4.6 billion, down 281.34% from the prior year.
- Net Cash Flow came in at -$1.3 billion for Q2 2026 at Johnson & Johnson, down from $2.0 billion in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $14.3 billion in Q1 2025 to a low of -$20.1 billion in Q2 2025.
- Average Net Cash Flow over 5 years is -$82.3 million, with a median of -$405.0 million recorded in 2024.
- Year-over-year, Net Cash Flow jumped 414.6% in 2023 and plunged 3831.57% in 2025.
- Over 5 years, Net Cash Flow stood at -$4.0 billion in 2022, then soared by 149.65% to $2.0 billion in 2023, then jumped by 115.5% to $4.3 billion in 2024, then plunged by 66.34% to $1.5 billion in 2025, then tumbled by 187.35% to -$1.3 billion in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$1.3 billion in Q2 2026, $2.0 billion in Q1 2026, and $1.5 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -722.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | -851.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 918.27 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 374.50 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 407.41 Mn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 521.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -1.27 Bn |
| Mar 29, 2026 | 2.00 Bn |
| Dec 28, 2025 | 1.46 Bn |
| Sep 28, 2025 | -300.00 Mn |
| Jun 29, 2025 | -20.05 Bn |
| Mar 30, 2025 | 14.30 Bn |
| Dec 29, 2024 | 4.32 Bn |
| Sep 29, 2024 | -5.02 Bn |
| Jun 30, 2024 | -510.00 Mn |
| Mar 31, 2024 | 3.74 Bn |
| Dec 31, 2023 | 2.01 Bn |
| Oct 1, 2023 | -1.29 Bn |
| Jul 2, 2023 | -5.59 Bn |
| Apr 2, 2023 | 12.71 Bn |
| Jan 1, 2023 | -3.79 Bn |
| Apr 3, 2022 | -4.04 Bn |
| Oct 3, 2021 | 3.36 Bn |
| Jul 4, 2021 | 1.62 Bn |
| Apr 4, 2021 | -1.24 Bn |
| Jan 3, 2021 | -5.20 Bn |